Cargando…
Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
BACKGROUND: Epirubicin, cisplatin, and 5-FU (ECF) is one of the most commonly used first-line chemotherapy regimens in metastatic gastric cancer. However, due to protracted infusion schedule, need for special infusion pumps, and catheter-related complications, the practical utility and acceptability...
Autores principales: | Babu, K. Govind, Chaudhuri, Tamojit, Lakshmaiah, K. C., Dasappa, Lokanatha, Jacob, Linu Abraham, Suresh Babu, M. C., Rudresha, A. H., Lokesh, K. N., Rajeev, L. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498711/ https://www.ncbi.nlm.nih.gov/pubmed/31069184 http://dx.doi.org/10.4103/sajc.sajc_146_18 |
Ejemplares similares
-
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
por: Babu, K. Govind, et al.
Publicado: (2018) -
Metastatic gastrointestinal stromal tumor: A regional cancer center experience of 44 cases
por: Suresh Babu, M. C., et al.
Publicado: (2017) -
Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India
por: Rudresha, AH, et al.
Publicado: (2017) -
Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India
por: Haleshappa, Rudresha Antapura, et al.
Publicado: (2017) -
Primary central nervous system lymphoma in immunocompetent patients: A regional cancer center experience
por: Rudresha, A. H., et al.
Publicado: (2017)